Glassman Wealth Services’s Acceleron Pharma XLRN Stock Holding History

Glassman Wealth Services’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-114	Closed	-$20K	–	2047
2021 Q3	$20K	Hold	114	–	–	﹤0.01%	587
2021 Q2	$14K	Hold	114	–	–	﹤0.01%	677
2021 Q1	$15K	Buy	114 +12	+12%	+$1.55K	﹤0.01%	614
2020 Q4	$13K	Hold	102	–	–	﹤0.01%	657
2020 Q3	$11K	Buy	102 +71	+229%	+$7.07K	﹤0.01%	598
2020 Q2	$3K	Hold	31	–	–	﹤0.01%	804
2020 Q1	$3K	Hold	31	–	–	﹤0.01%	654
2019 Q4	$2K	Buy	31 +3	+11%	+$137	﹤0.01%	823
2019 Q3	$1K	Buy	28 +7	+33%	+$304	﹤0.01%	983
2019 Q2	$1K	Hold	21	–	–	﹤0.01%	994
2019 Q1	$1K	Buy	+21	New	+$922	﹤0.01%	962

Glassman Wealth Services's XLRN Position: Q4 2021 in Review

Glassman Wealth Services sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 114 shares — an estimated $20K sold.

Glassman Wealth Services first reported a position in XLRN in Q1 2019 and held it in 11 quarters. The position peaked at $20K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Glassman Wealth Services reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Glassman Wealth Services sold 114 Acceleron Pharma shares in Q4 2021, an estimated $20K.
Glassman Wealth Services first reported a position in Acceleron Pharma in Q1 2019 and held it in 11 quarters.
Glassman Wealth Services's Acceleron Pharma position peaked at $20K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Glassman Wealth Services's 13F filing for Q4 2021, filed 14 Feb 2022.